• Drug companies interested in Louisiana hepatitis C drug plan firstwordpharma
    March 03, 2019
    Louisiana's Department of Health announced that Merck & Co., AbbVie and Gilead Sciences are interested in the state's plan to use a Netflix-style subscription model to buy access to hepatitis C drugs for Medicaid patients and prisoners, as reported in the
PharmaSources Customer Service